🇺🇸 FDA
Patent

US 9278089

Method of treating HCV infection with a small molecule CHK2 inhibitor

granted A61KA61K31/404A61K31/4178

Quick answer

US patent 9278089 (Method of treating HCV infection with a small molecule CHK2 inhibitor) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/404, A61K31/4178, A61K31/4184, A61K31/454